GNH USA

Europe — EMA

Manitol Mein

GNH USA supplies Manitol Mein (Mannitol), an osmotic diuretic for intracranial pressure reduction and acute renal failure. Request a quote for global supply.

Mannitol

Request sourcing

1
Pack/s

What is Mannitol?

Mannitol, the active ingredient in Manitol Mein, is an osmotic diuretic presented as an intravenous solution for intravenous use. It is employed to lower elevated intracranial pressure, to promote diuresis in acute oliguric renal failure, and to facilitate the removal of certain toxins in hospitalized patients.

GNH USA supplies Manitol Mein as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global healthcare facilities.

What is Mannitol used for?

Mannitol is used in clinical settings to manage conditions that benefit from osmotic diuresis and intracranial pressure reduction.

Intracranial hypertension: lowers elevated intracranial pressure, helping prevent cerebral edema. Acute oliguric renal failure: increases urine output to support renal clearance. Elevated intra‑ocular pressure during ophthalmic surgery: reduces pressure to protect optic structures.

What are the side effects of Mannitol?

Mannitol may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea: feeling of queasiness. - Vomiting: occasional emesis. - Thirst or dry mouth: increased sensation of dryness. - Electrolyte imbalance (e.g., hyponatremia): mild shifts in serum sodium. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in lungs. - Severe hypotension: marked drop in blood pressure. - Anaphylactic reaction: rare allergic response. - Acute renal failure worsening: unexpected decline in kidney function. - Cardiac arrhythmia: irregular heart rhythm. - Seizures: neurologic events.

What precautions apply to Mannitol?

When using Mannitol, clinicians should observe several safety measures to minimize risks.

- Monitor fluid balance: record input and output closely. - Check serum electrolytes: assess sodium, potassium, and osmolality before and during therapy. - Use cautiously in heart failure: risk of volume overload. - Avoid in severe dehydration: may exacerbate hypotension. - Adjust dose in renal impairment: reduced clearance requires careful titration. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Mannitol interact with?

Mannitol can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Loop diuretics: combined use may cause excessive diuresis and electrolyte loss. - Lithium: Mannitol may increase lithium levels, raising toxicity risk. - Antihypertensive agents: additive blood pressure lowering effect.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt the diuretic response. - Aminoglycoside antibiotics: concurrent use can heighten renal toxicity. - Radiographic contrast media: combined renal stress may precipitate acute kidney injury.

Frequently asked questions

What is Manitol Mein used for?+
Manitol Mein is an intravenous formulation of mannitol used primarily to lower elevated intracranial pressure, to promote diuresis in acute oliguric renal failure, and to aid in the removal of certain toxins or excess fluids during hospital treatment.
How does Mannitol work?+
Mannitol increases plasma osmolarity, drawing water from intracellular and interstitial spaces into the bloodstream. This expands plasma volume, enhances renal perfusion, and promotes the excretion of water and electrolytes, while also reducing cerebral edema by creating an osmotic gradient across the blood‑brain barrier.
What determines the dose of Manitol?+
The dose of Manitol is individualized by the prescribing clinician based on the patient’s condition, weight, renal function, and therapeutic goal. Dosage regimens are established in hospital protocols and adjusted according to clinical response and laboratory monitoring.
Is Mannitol safe during pregnancy or breastfeeding?+
Safety data for mannitol in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Manitol Mein from GNH USA?+
To order Manitol Mein, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Mannitol compare with other osmotic diuretics?+
Mannitol is a non‑ionic sugar alcohol that provides rapid osmotic diuresis and intracranial pressure reduction, whereas alternatives such as hypertonic saline rely on sodium chloride to achieve similar effects. Mannitol’s renal excretion and lower sodium load make it preferable in many neurosurgical and renal‑failure scenarios, though choice depends on patient‑specific factors.
What are the recommended storage conditions for Manitol Mein?+
Manitol Mein should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability and sterility.
How is Manitol administered to patients?+
Manitol is administered intravenously, typically as a sterile solution infused over a controlled period. The infusion rate and total volume are determined by the prescriber, with careful monitoring of vital signs, urine output, and serum electrolytes throughout the administration.
What are the most serious risks to watch for with Mannitol therapy?+
Serious risks include pulmonary edema, severe hypotension, anaphylactic reactions, worsening renal failure, cardiac arrhythmias, and seizures. Prompt recognition of these events and immediate medical intervention are essential to mitigate harm.
Who should not use Mannitol?+
Mannitol is contraindicated in patients with severe dehydration, active intracranial bleeding, uncontrolled heart failure, severe pulmonary edema, or known hypersensitivity to mannitol. Caution is also advised in individuals with significant renal impairment or electrolyte disturbances.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Mannitol
Route
Intravenous Use
Manufacturer
Fresenius Kabi España S.A.U.
Origin
EU

Related products